Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
30 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
146.3 rhumatos / 100 000 hab. — département bien doté
5ans d'exercice (thèse 2021)·16 publications sur 5 ans
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
22
22 articles ont été cités au moins 22fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
2 975
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
107
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
43
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Inserm · Centre Hospitalier Régional et Universitaire de Nancy · Interdisciplinarité en Santé Publique Interventions et Instruments de mesure complexes – Région Est
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis
2026ArticleNeurology
External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims database
2026ArticleMultiple Sclerosis and Related Disorders
Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study
2026ArticleCNS Drugs
Progression independent of relapse and MRI activity and treatment strategies in multiple sclerosis
2026ArticleBrain - A Journal of Neurology
Treatment Discontinuation in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
2026ArticleJAMA neurology
Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis
2026ArticleJournal of Neurology, Neurosurgery and Psychiatry
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis
2025ArticleJAMA neurology
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis
2025ArticleNeurology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CHRU NANCY - HOPITAL CENTRAL
29 AV DE LATTRE DE TASSIGNY CO 60034, 54035 NANCY CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Multiple sclerosis and related disorders · 2020
Brain : a journal of neurology · 2023
Abstract The radiologically isolated syndrome (RIS) was defined in 2009 as the presence of asymptomatic, incidentally identified demyelinating-appearing white matter lesions in the CNS within individuals lacking symptoms typical of multiple sclerosis (MS). The RIS criteria have been validated and predict the transition to symptomatic MS reliably. The performance of RIS criteria that require fewer MRI lesions is unknown. 2009-RIS subjects, by definition, fulfil three to four of four criteria for 2005 dissemination in space (DIS) and subjects fulfilling only one or two lesions in at least one 2017 DIS location were identified within 37 prospective databases. Univariate and multivariate Cox regression models were used to identify predictors of a first clinical event. Performances of different groups were calculated. Seven hundred and forty-seven subjects (72.2% female, mean age 37.7 ± 12.3 years at the index MRI) were included. The mean clinical follow-up time was 46.8 ± 45.4 months. All subjects had focal T2 hyperintensities suggestive of inflammatory demyelination on MRI; 251 (33.6%) fulfilled one or two 2017 DIS criteria (designated as Groups 1 and 2, respectively), and 496 (66.4%) fulfilled three or four 2005 DIS criteria representing 2009-RIS subjects. Group 1 and 2 subjects were younger than the 2009-RIS group and were more likely to develop new T2 lesions over time (P < 0.001). Groups 1 and 2 were similar regarding survival distribution and risk factors for transition to MS. At 5 years, the cumulative probability for a clinical event was 29.0% for Groups 1 and 2 compared to 38.7% for 2009-RIS (P = 0.0241). The presence of spinal cord lesions on the index scan and CSF-restricted oligoclonal bands in Groups 1–2 increased the risk of symptomatic MS evolution at 5 years to 38%, comparable to the risk of development in the 2009-RIS group. The presence of new T2 or gadolinium-enhancing lesions on follow-up scans independently increased the risk of presenting with a clinical event (P < 0.001). The 2009-RIS subjects or Groups 1 and 2 with at least two of the risk factors for a clinical event demonstrated better sensitivity (86.0%), negative predictive value (73.1%), accuracy (59.8%) and area under the curve (60.7%) compared to other criteria studied. This large prospective cohort brings Class I evidence that subjects with fewer lesions than required in the 2009 RIS criteria evolve directly to a first clinical event at a similar rate when additional risk factors are present. Our results provide a rationale for revisions to existing RIS diagnostic criteria.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Neurology · 2026 · Journal Article
Gavoille A, Kerbrat A, Edan G, Le Page E, et al.
JAMA neurology · 2026 · Journal Article
Boudot de la Motte M, Gavoille A, Papeix C, Audoin B, et al.
Brain : a journal of neurology · 2026 · Journal Article
Rollot F, Casey R, Kerbrat A, Edan G, et al.
Neurology · 2025 · Journal Article
Gavoille A, Leray E, Marignier R, Rollot F, et al.
Neurology · 2025 · Journal Article
Robin C, Rollot F, Lefort M, Casey R, et al.
Journal of neurology, neurosurgery, and psychiatry · 2025 · Journal Article
Lorscheider J, Signori A, Subramaniam S, Benkert P, et al.
Frontiers in immunology · 2024 · Journal Article
Rodriguez S, Couloume L, Ferrant J, Vince N, et al.
Neurology · 2024 · Journal Article
Hay M, Rollot F, Casey R, Kerbrat A, et al.
Brain and behavior · 2024 · Journal Article
Dos Santos A, Courtin E, Ruet A, Duffau P, et al.
Neurology · 2024 · Journal Article
Deschamps R, Guillaume J, Ciron J, Audoin B, et al.
Journal of neurology · 2024 · Journal Article
Ferrand M, Epstein J, Soudant M, Guillemin F, et al.
Brain : a journal of neurology · 2023 · Journal Article
Lebrun-Frénay C, Okuda DT, Siva A, Landes-Chateau C, et al.
JAMA network open · 2021 · Journal Article
Lebrun-Frénay C, Rollot F, Mondot L, Zephir H, et al.
European journal of neurology · 2021 · Journal Article
Louapre C, Maillart E, Papeix C, Zeidan S, et al.
European journal of neurology · 2021 · Journal Article
Mathey G, Ancel T, Garot T, Soudant M, et al.
Journal of neurology · 2020 · Journal Article
Kaminsky AL, Omorou AY, Soudant M, Pittion-Vouyovitch S, et al.
JAMA neurology · 2020 · Journal Article
Louapre C, Collongues N, Stankoff B, Giannesini C, et al.
Journal of neurology, neurosurgery, and psychiatry · 2026 · Journal Article
Roos I, Sharmin S, Horakova D, Kubala Havrdova E, et al.
CNS drugs · 2026 · Journal Article
Roos I, Sharmin S, Ozakbas S, Alroughani R, et al.
Journal of neurology, neurosurgery, and psychiatry · 2026 · Journal Article
Gavoille A, Nourredine M, Rollot F, Casey R, et al.
Multiple sclerosis (Houndmills, Basingstoke, England) · 2024 · Observational Study
Venet M, Lepine A, Maarouf A, Biotti D, et al.
Multiple sclerosis and related disorders · 2020 · Journal Article
Whittam DH, Cobo-Calvo A, Lopez-Chiriboga AS, Pardo S, et al.
Journal of neurology, neurosurgery, and psychiatry · 2026 · Journal Article
Gavoille A, Nourredine M, Rollot F, Casey R, et al.
Trials · 2020 · Clinical Trial Protocol
Metzger-Peter K, Kremer LD, Edan G, Loureiro De Sousa P, et al.
Journal of neurology, neurosurgery, and psychiatry · 2026 · Journal Article
Roos I, Sharmin S, Horakova D, Kubala Havrdova E, et al.
Advances in therapy · 2025 · Journal Article
de Sèze J, Labauge P, Liblau R, Martinez M, et al.
JAMA neurology · 2024 · Journal Article
Gavoille A, Rollot F, Casey R, Kerbrat A, et al.
Journal of neurology · 2024 · Journal Article
Makhani N, Lebrun-Frenay C, Siva A, Shabanova V, et al.
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study
Objectives:We aim to (1) determine the frequency and distinctive features of short myelitis (SM) and longitudinally extensive transverse myelitis (LETM) in a cohort of adults with myelin oligodendrocyte glycoprotein (MOG
Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome
BackgroundSteps towards the development of diagnostic criteria are needed for children with the radiologically isolated syndrome to identify children at risk of clinical demyelination.ObjectivesTo evaluate the 2005 and 2
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study
Objectives:We aim to (1) determine the frequency and distinctive features of short myelitis (SM) and longitudinally extensive transverse myelitis (LETM) in a cohort of adults with myelin oligodendrocyte glycoprotein (MOG
51ème Semaine Médicale de Lorraine Nancy 2016 : Pathologie inflammatoire, SEP : qu’est-ce qu’une poussée de SEP, comment la traiter ?
Titre : 51ème Semaine Médicale de Lorraine Nancy 2016 : Pathologie inflammatoire, SEP : qu’est-ce qu’une poussée de SEP, comment la traiter ? Intervenant : Dr Guillaume MATHEY ------------------PROGRAMME MERCREDI 16
Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome
BackgroundSteps towards the development of diagnostic criteria are needed for children with the radiologically isolated syndrome to identify children at risk of clinical demyelination.ObjectivesTo evaluate the 2005 and 2
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
Therapeutic advances in neurological disorders · 2023 · Journal Article
Bekkour I, Courtin E, Dulau-Metras C, Duffau P, et al.
Scientific reports · 2022 · Journal Article
Gbaguidi B, Guillemin F, Soudant M, Debouverie M, et al.
European journal of neurology · 2021 · Journal Article
Deschamps R, Pique J, Ayrignac X, Collongues N, et al.
JAMA neurology · 2020 · Journal Article
Vukusic S, Rollot F, Casey R, Pique J, et al.